Beam Therapeutics Inc (BEAM)
23.58
-0.91
(-3.72%)
USD |
NASDAQ |
Nov 21, 16:00
23.60
+0.02
(+0.08%)
After-Hours: 07:56
Beam Therapeutics Enterprise Value: 1.027B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.027B |
| November 20, 2024 | 1.102B |
| November 19, 2024 | 1.168B |
| November 18, 2024 | 1.072B |
| November 15, 2024 | 1.066B |
| November 14, 2024 | 1.253B |
| November 13, 2024 | 1.351B |
| November 12, 2024 | 1.388B |
| November 11, 2024 | 1.587B |
| November 08, 2024 | 1.315B |
| November 07, 2024 | 1.235B |
| November 06, 2024 | 1.279B |
| November 05, 2024 | 1.056B |
| November 04, 2024 | 1.091B |
| November 01, 2024 | 972.98M |
| October 31, 2024 | 888.51M |
| October 30, 2024 | 937.37M |
| October 29, 2024 | 910.04M |
| October 28, 2024 | 919.43M |
| October 25, 2024 | 853.39M |
| October 24, 2024 | 897.97M |
| October 23, 2024 | 875.68M |
| October 22, 2024 | 951.63M |
| October 21, 2024 | 985.48M |
| October 18, 2024 | 1.027B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.085B |
| October 16, 2024 | 1.278B |
| October 15, 2024 | 1.249B |
| October 14, 2024 | 1.269B |
| October 11, 2024 | 1.115B |
| October 10, 2024 | 975.57M |
| October 09, 2024 | 1.009B |
| October 08, 2024 | 994.56M |
| October 07, 2024 | 1.005B |
| October 04, 2024 | 1.007B |
| October 03, 2024 | 968.14M |
| October 02, 2024 | 1.014B |
| October 01, 2024 | 1.007B |
| September 30, 2024 | 1.097B |
| September 27, 2024 | 1.056B |
| September 26, 2024 | 1.062B |
| September 25, 2024 | 1.011B |
| September 24, 2024 | 1.033B |
| September 23, 2024 | 1.029B |
| September 20, 2024 | 1.106B |
| September 19, 2024 | 1.138B |
| September 18, 2024 | 1.094B |
| September 17, 2024 | 1.100B |
| September 16, 2024 | 1.103B |
| September 13, 2024 | 1.159B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
388.81M
Minimum
Oct 20 2023
7.996B
Maximum
Jul 01 2021
2.357B
Average
1.571B
Median
May 09 2023
Enterprise Value Benchmarks
| Bruker Corp | 10.71B |
| Perspective Therapeutics Inc | -63.40M |
| Electromed Inc | 223.55M |
| Xtant Medical Holdings Inc | 85.83M |
| Myomo Inc | 138.56M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -96.67M |
| Revenue (Quarterly) | 14.27M |
| Total Expenses (Quarterly) | 120.77M |
| EPS Diluted (Quarterly) | -1.17 |
| Profit Margin (Quarterly) | -677.5% |
| Earnings Yield | -7.46% |
| Normalized Earnings Yield | -6.963 |